IPF-PRO ILD-PRO BIO

What this means for you

Registered since 29 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

88286593

Registration number

5899026

Mark type

Design + words

Filed

01 Feb 2019

Published for opposition

18 Jun 2019

Registered

29 Oct 2019

Attorney of record

Scott J. Major

Goods and services

• Class 035 — Advertising and business services: Maintaining registries of patients with idiopathic pulmonary fibrosis and with interstitial lung diseases; promoting awareness of idiopathic pulmonary fibrosis and interstitial lung diseases, their symptoms, prevention and treatment, and promoting awareness of biomarker testing therefor
• Class 044 — Medical, beauty and agricultural services: Providing medical and pharmaceutical information regarding idiopathic pulmonary fibrosis and interstitial lung diseases, their symptoms, prevention and treatment, and providing medical information regarding biomarker testing relating thereto

Owner

• Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
• Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
• Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US

Prosecution history

• 29 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 29 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
• 24 Sept 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 23 Sept 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 21 Sept 2019 — STATEMENT OF USE PROCESSING COMPLETE
• 30 Aug 2019 — USE AMENDMENT FILED
• 21 Sept 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 30 Aug 2019 — TEAS STATEMENT OF USE RECEIVED
• 13 Aug 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 18 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 18 Jun 2019 — PUBLISHED FOR OPPOSITION
• 29 May 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 15 May 2019 — ASSIGNED TO LIE
• 29 Apr 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 25 Apr 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED